Your browser doesn't support javascript.
loading
Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: The ENIGMA adventure.
Hoogman, Martine; van Rooij, Daan; Klein, Marieke; Boedhoe, Premika; Ilioska, Iva; Li, Ting; Patel, Yash; Postema, Merel C; Zhang-James, Yanli; Anagnostou, Evdokia; Arango, Celso; Auzias, Guillaume; Banaschewski, Tobias; Bau, Claiton H D; Behrmann, Marlene; Bellgrove, Mark A; Brandeis, Daniel; Brem, Silvia; Busatto, Geraldo F; Calderoni, Sara; Calvo, Rosa; Castellanos, Francisco X; Coghill, David; Conzelmann, Annette; Daly, Eileen; Deruelle, Christine; Dinstein, Ilan; Durston, Sarah; Ecker, Christine; Ehrlich, Stefan; Epstein, Jeffery N; Fair, Damien A; Fitzgerald, Jacqueline; Freitag, Christine M; Frodl, Thomas; Gallagher, Louise; Grevet, Eugenio H; Haavik, Jan; Hoekstra, Pieter J; Janssen, Joost; Karkashadze, Georgii; King, Joseph A; Konrad, Kerstin; Kuntsi, Jonna; Lazaro, Luisa; Lerch, Jason P; Lesch, Klaus-Peter; Louza, Mario R; Luna, Beatriz; Mattos, Paulo.
Afiliación
  • Hoogman M; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van Rooij D; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.
  • Klein M; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.
  • Boedhoe P; Department of Cognitive Neuroscience, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Ilioska I; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Li T; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.
  • Patel Y; Department of Psychiatry, University Medical Center Utrecht, UMC Utrecht Brain Center, Utrecht, The Netherlands.
  • Postema MC; Department of Psychiatry, Department of Anatomy & Neurosciences, Amsterdam Neuroscience, Amsterdam UMC Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Zhang-James Y; Department of Cognitive Neuroscience, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Anagnostou E; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Arango C; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.
  • Auzias G; Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada.
  • Banaschewski T; Department of Language & Genetics, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands.
  • Bau CHD; Department of Psychiatry and behavioral sciences, SUNY Upstate Medical University, Syracuse, New York, USA.
  • Behrmann M; Department of Pediatrics University of Toronto, Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada.
  • Bellgrove MA; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, Madrid, Spain.
  • Brandeis D; School of Medicine, Universidad Complutense, Madrid, Spain.
  • Brem S; INT UMR 7289, Aix-Marseille Université, CNRS, France.
  • Busatto GF; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany.
  • Calderoni S; Department of Genetics, Institute of Biosciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
  • Calvo R; Adulthood ADHD Outpatient Program (ProDAH), Clinical Research Center, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
  • Castellanos FX; Developmental Psychiatry Program, Experimental Research Center, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
  • Coghill D; Department of Psychology and Neuroscience Institute, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA.
  • Conzelmann A; Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia.
  • Daly E; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany.
  • Deruelle C; Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zurich, Zurich, Switzerland.
  • Dinstein I; The Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland.
  • Durston S; Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zurich, Zurich, Switzerland.
  • Ecker C; The Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland.
  • Ehrlich S; Laboratory of Psychiatric Neuroimaging (LIM-21), Departamento e Instituto de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Epstein JN; Department of Developmental Neuroscience, IRCCS Fondazione Stella Maris, Pisa, Italy.
  • Fair DA; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Fitzgerald J; Department of Child and Adolescent Psychiatry and Psychology, Hospital Clínic, Barcelona, Spain.
  • Freitag CM; IDIBAPS, Barcelona, Spain.
  • Frodl T; Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain.
  • Gallagher L; Department of Medicine, University of Barcelona, Barcelona, Spain.
  • Grevet EH; Department of Child and Adolescent Psychiatry, Hassenfeld Children's Hospital at NYU Langone, New York, New York, USA.
  • Haavik J; Department of Child and Adolescent Psychiatry, Hassenfeld Children's Hospital at NYU Langone, New York, New York, USA.
  • Hoekstra PJ; Nathan Kline Institute for Psychiatric Research, Orangeburg, New York, USA.
  • Janssen J; Department of Paediatrics and Psychiatry, University of Melbourne, Melbourne, Victoria, Australia.
  • Karkashadze G; Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
  • King JA; Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Psychiatry and Psychotherapy, Tübingen, Germany.
  • Konrad K; PFH - Private University of Applied Sciences, Department of Psychology (Clinical Psychology II), Göttingen, Germany.
  • Kuntsi J; Department of Forensic and Neurodevelopmental Science, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Lazaro L; INT UMR 7289, Aix-Marseille Université, CNRS, France.
  • Lerch JP; Department of Psychology, Ben Gurion University, Beer Sheva, Israel.
  • Lesch KP; NICHE lab, Deptartment of Psychiatry, UMC Utrecht Brain Center, Utrecht, The Netherlands.
  • Louza MR; Department of Forensic and Neurodevelopmental Science, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Luna B; Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Autism Research and Intervention Center of Excellence, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
  • Mattos P; Division of Psychological & Social Medicine and Developmental Neurosciences, Faculty of Medicine, Technischen Universität Dresden, Dresden, Germany.
Hum Brain Mapp ; 43(1): 37-55, 2022 01.
Article en En | MEDLINE | ID: mdl-32420680
ABSTRACT
Neuroimaging has been extensively used to study brain structure and function in individuals with attention deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) over the past decades. Two of the main shortcomings of the neuroimaging literature of these disorders are the small sample sizes employed and the heterogeneity of methods used. In 2013 and 2014, the ENIGMA-ADHD and ENIGMA-ASD working groups were respectively, founded with a common goal to address these limitations. Here, we provide a narrative review of the thus far completed and still ongoing projects of these working groups. Due to an implicitly hierarchical psychiatric diagnostic classification system, the fields of ADHD and ASD have developed largely in isolation, despite the considerable overlap in the occurrence of the disorders. The collaboration between the ENIGMA-ADHD and -ASD working groups seeks to bring the neuroimaging efforts of the two disorders closer together. The outcomes of case-control studies of subcortical and cortical structures showed that subcortical volumes are similarly affected in ASD and ADHD, albeit with small effect sizes. Cortical analyses identified unique differences in each disorder, but also considerable overlap between the two, specifically in cortical thickness. Ongoing work is examining alternative research questions, such as brain laterality, prediction of case-control status, and anatomical heterogeneity. In brief, great strides have been made toward fulfilling the aims of the ENIGMA collaborations, while new ideas and follow-up analyses continue that include more imaging modalities (diffusion MRI and resting-state functional MRI), collaborations with other large databases, and samples with dual diagnoses.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno por Déficit de Atención con Hiperactividad / Encéfalo / Neuroimagen / Trastorno del Espectro Autista Límite: Humans Idioma: En Revista: Hum Brain Mapp Asunto de la revista: CEREBRO Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno por Déficit de Atención con Hiperactividad / Encéfalo / Neuroimagen / Trastorno del Espectro Autista Límite: Humans Idioma: En Revista: Hum Brain Mapp Asunto de la revista: CEREBRO Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos
...